Search Results - Jason M. Held

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    The TRIM4 E3 ubiquitin ligase degrades TPL2 and is modulated by oncogenic KRAS by Sapana Bansod, Paarth B. Dodhiawala, Yutong Geng, Ashenafi Bulle, Peng Liu, Lin Li, Reid Townsend, Patrick M. Grierson, Jason M. Held, Hema Adhikari, Kian-Huat Lim

    Published in Cell Reports (2024-09-01)
    Get full text
    Article


  2. 2

    Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer by Ashenafi Bulle, Peng Liu, Kuljeet Seehra, Sapana Bansod, Yali Chen, Kiran Zahra, Vikas Somani, Iftikhar Ali Khawar, Hung-Po Chen, Paarth B. Dodhiawala, Lin Li, Yutong Geng, Chia-Kuei Mo, Jay Mahsl, Li Ding, Ramaswamy Govindan, Sherri Davies, Jacqueline Mudd, William G. Hawkins, Ryan C. Fields, David G. DeNardo, Deborah Knoerzer, Jason M. Held, Patrick M. Grierson, Andrea Wang-Gillam, Marianna B. Ruzinova, Kian-Huat Lim

    Published in Nature Communications (2024-03-01)
    Get full text
    Article


Search Tools: